Scar and Contracture: Biological Principles

Hand Clinics

Volumn 25, Issue 4, 2009, Pages 511-528

  Kwan, Peter ^a   Hori, Keijiro ^a   Ding, Jie ^a   Tredget, Edward E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Burns; Cicatrix; Contracture; Hypertrophic scar; Wound healing

Indexed keywords

ALPHA2B INTERFERON; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CONNECTIVE TISSUE GROWTH FACTOR; CORTICOSTEROID DERIVATIVE; CYCLINE; CYTOKINE; FLUOROURACIL; GAMMA INTERFERON; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; MANNOSE 6 PHOSPHATE; PLATELET DERIVED GROWTH FACTOR; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA3; SCLEROPROTEIN; SILICONE GEL; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; TRIAMCINOLONE ACETONIDE;

ANTIINFLAMMATORY ACTIVITY; BURN CONTRACTURE; BURN SCAR; CD4+ T LYMPHOCYTE; CELL INTERACTION; COMPRESSION GARMENT; CRYOSURGERY; CYTOKINE PRODUCTION; HUMAN; HYPERTROPHIC SCAR; IMMUNOREGULATION; LOW LEVEL LASER THERAPY; MYOFIBROBLAST; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN SYNTHESIS INHIBITION; REVIEW; SKIN FIBROBLAST; SPLINTING; SPLIT THICKNESS SKIN GRAFT; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TISSUE ENGINEERING; TISSUE REGENERATION; WOUND CONTRACTION; WOUND DRESSING; WOUND HEALING IMPAIRMENT;

ANIMALS; CICATRIX; CONTRACTURE; CYTOKINES; FIBROBLASTS; HUMANS; KERATINOCYTES; PLATELET-DERIVED GROWTH FACTOR; SPLINTS; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 70349629994     PISSN: 07490712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hcl.2009.06.007     Document Type: Review

References (218)

1. Ewings E.L., and Pollack J. Pediatric upper extremity burns: outcomes of emergency department triage and outpatient management. J Burn Care Res 29 1 (2008) 77-81
2. Islam S.S., Nambiar A.M., Doyle E.J., et al. Epidemiology of work-related burn injuries: experience of a state-managed workers' compensation system. J Trauma 49 6 (2000) 1045-1051
3. Fagenholz P.J., Sheridan R.L., Harris N.S., et al. National study of emergency department visits for burn injuries, 1993 to 2004. J Burn Care Res 28 5 (2007) 681-690
4. Centers for Disease Control. WISQARS: nonfatal injury reports (2008), Centers for Disease Control, Atlanta (GA)
5. Pruitt B.A., Wolf S.E., Mason A.D., et al. Epidemiological, demographic and outcome characteristics of burn injury. In: Herndon D.N. (Ed). Total burn care (2007), Saunders, Philadelphia 14-32
6. Bombaro K.M., Engrav L.H., Carrougher G.J., et al. What is the prevalence of hypertrophic scarring following burns?. Burns 29 4 (2003) 299-302
7. American Burn Association. Guidelines for the operation of burn centers. J Burn Care Res 28 1 (2007) 134-141
8. van Zuijlen P.P., Kreis R.W., Vloemans A.F., et al. The prognostic factors regarding long-term functional outcome of full-thickness hand burns. Burns 25 8 (1999) 709-714
9. Gangemi E.N., Gregori D., Berchialla P., et al. Epidemiology and risk factors for pathologic scarring after burn wounds. Arch Facial Plast Surg 10 2 (2008) 93-102
10. Monstrey S., Hoeksema H., Verbelen J., et al. Assessment of burn depth and burn wound healing potential. Burns 34 6 (2008) 761-769
11. Robson M.C., Smith D.J., VanderZee A.J., et al. Making the burned hand functional. Clin Plast Surg 19 3 (1992) 663-671
12. Greenhalgh D.G., and Vu H.L. Acute management of the burned hand and electrical injuries. In: Mathes S.J. (Ed). Plastic surgery (2006), Saunders, Philadelphia 587-603
13. Bayat A., McGrouther D.A., and Ferguson M.W.J. Skin scarring. BMJ 326 7380 (2003) 88-92
14. Engrav L.H., Garner W.L., and Tredget E.E. Hypertrophic scar, wound contraction and hyper-hypopigmentation. J Burn Care Res 28 4 (2007) 593-597
15. Singer A.J., and Clark R.A.F. Cutaneous wound healing. N Engl J Med 341 10 (1999) 738-746
16. Rhett J., Ghatnekar G., Palatinus J., et al. Novel therapies for scar reduction and regenerative healing of skin wounds. Trends Biotechnol 26 4 (2008) 173-180
17. Martin P. Wound healing-aiming for perfect skin regeneration. Science 276 5309 (1997) 75-81
18. Clark R.A.F., Ghosh K., and Tonnesen M.G. Tissue engineering for cutaneous wounds. J Invest Dermatol 127 5 (2007) 1018-1029
19. Baum C.L., and Arpey C.J. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg 31 6 (2005) 674-686 [discussion: 686]
20. Cubison T.C.S., Pape S.A., and Parkhouse N. Evidence for the link between healing time and the development of hypertrophic scars (HTS) in paediatric burns due to scald injury. Burns 32 8 (2006) 992-999
21. Engrav L.H., Heimbach D.M., Reus J.L., et al. Early excision and grafting vs. nonoperative treatment of burns of indeterminant depth: a randomized prospective study. J Trauma 23 11 (1983) 1001-1004
22. Wasiak J., Cleland H., and Campbell F. Dressings for superficial and partial thickness burns. Cochrane Database Syst Rev 4 (2008) CD002106
23. Dunkin C.S.J., Pleat J.M., Gillespie P.H., et al. Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers. Plast Reconstr Surg 119 6 (2007) 1722-1732
24. Scott P.G., Ghahary A., and Tredget E.E. Molecular and cellular aspects of fibrosis following thermal injury. Hand Clin 16 2 (2000) 271-287
25. Ali-Bahar M., Bauer B., Tredget E.E., et al. Dermal fibroblasts from different layers of human skin are heterogeneous in expression of collagenase and types I and III procollagen mRNA. Wound Repair Regen 12 2 (2004) 175-182
26. Feldman S.R., Trojanowska M., Smith E.A., et al. Differential responses of human papillary and reticular fibroblasts to growth factors. Am J Med Sci 305 4 (1993) 203-207
27. Harper R.A., and Grove G. Human skin fibroblasts derived from papillary and reticular dermis: differences in growth potential in vitro. Science 204 4392 (1979) 526-527
28. Lochner K., Gaemlich A., Sudel K.M., et al. Expression of decorin and collagens I and III in different layers of human skin in vivo: a laser capture microdissection study. Biogerontology 8 3 (2007) 269-282
29. Schafer I.A., Shapiro A., Kovach M., et al. The interaction of human papillary and reticular fibroblasts and human keratinocytes in the contraction of three-dimensional floating collagen lattices. Exp Cell Res 183 1 (1989) 112-125
30. Schonherr E., Beavan L.A., Hausser H., et al. Differences in decorin expression by papillary and reticular fibroblasts in vivo and in vitro. Biochem J 290 Pt 3 (1993) 893-899
31. Sorrell J.M., Baber M.A., and Caplan A.I. Site-matched papillary and reticular human dermal fibroblasts differ in their release of specific growth factors/cytokines and in their interaction with keratinocytes. J Cell Physiol 200 1 (2004) 134-145
32. Sorrell J.M., and Caplan A.I. Fibroblast heterogeneity: more than skin deep. J Cell Sci 117 Pt 5 (2004) 667-675
33. Sorrell J.M., Baber M.A., and Caplan A.I. Human dermal fibroblast subpopulations; differential interactions with vascular endothelial cells in coculture: nonsoluble factors in the extracellular matrix influence interactions. Wound Repair Regen 16 2 (2008) 300-309
34. Barrientos S., Stojadinovic O., Golinko M.S., et al. Growth factors and cytokines in wound healing. Wound Repair Regen 16 5 (2008) 585-601
35. Andrae J., Gallini R., and Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22 10 (2008) 1276-1312
36. Werner S., and Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 83 3 (2003) 835-870
37. Powell D.W., Mifflin R.C., Valentich J.D., et al. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Phys 277 1 Pt 1 (1999) C1-C9
38. Bonner J.C. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev 15 4 (2004) 255-273
39. Trojanowska M. Role of PDGF in fibrotic diseases and systemic sclerosis. Rheumatology (Oxford) 47 Suppl 5 (2008) v2-v4
40. Younai S., Venters G., Vu S., et al. Role of growth factors in scar contraction: an in vitro analysis. Ann Plast Surg 36 5 (1996) 495-501
41. Abdollahi A., Li M., Ping G., et al. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med 201 6 (2005) 925-935
42. Distler J.H.W., Jungel A., Huber L.C., et al. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis Rheum 56 1 (2007) 311-322
43. Gordon K., and Blobe G. Role of transforming growth factor-β superfamily signaling pathways in human disease. Biochim Biophys Acta 1782 4 (2008) 197-228
44. Prud'homme G.J. Pathobiology of transforming growth factor b in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest 87 11 (2007) 1077-1091
45. Leask A., and Abraham D.J. TGF-beta signaling and the fibrotic response. FASEB J 18 7 (2004) 816-827
46. Roberts A.B. Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24 2-3 (1998) 111-119
47. Cutroneo K.R. TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring. Wound Repair Regen 15 Suppl 1 (2007) S54-S60
48. Wakefield L.M., Smith D.M., Masui T., et al. Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol 105 2 (1987) 965-975
49. Postlethwaite A.E., Keski-Oja J., Moses H.L., et al. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med 165 1 (1987) 251-256
50. Ignotz R.A., and Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261 9 (1986) 4337-4345
51. Edwards D.R., Murphy G., Reynolds J.J., et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6 7 (1987) 1899-1904
52. Tredget E.E., Shankowsky H.A., Pannu R., et al. Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b. Plast Reconstr Surg 102 5 (1998) 1317-1328 [discussion: 1329-30]
53. Wang R., Ghahary A., Shen Q., et al. Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells. Wound Repair Regen 8 2 (2000) 128-137
54. Lanning D.A., Nwomeh B.C., Montante S.J., et al. TGF-beta1 alters the healing of cutaneous fetal excisional wounds. J Pediatr Surg 34 5 (1999) 695-700
55. Occleston N.L., Laverty H.G., O'Kane S., et al. Prevention and reduction of scarring in the skin by transforming growth factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical. J Biomater Sci Polym Ed 19 8 (2008) 1047-1063
56. Occleston N.L., O'Kane S., Goldspink N., et al. New therapeutics for the prevention and reduction of scarring. Drug Discov Today 13 21-22 (2008) 973-981
57. Bock O., Yu H., Zitron S., et al. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Acta Derm Venereol 85 3 (2005) 216-220
58. Perbal B. CCN proteins: multifunctional signalling regulators. Lancet 363 9402 (2004) 62-64
59. Grotendorst G.R. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 8 3 (1997) 171-179
60. Leask A., and Abraham D.J. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol 81 6 (2003) 355-363
61. Ihn H. Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr Opin Rheumatol 14 6 (2002) 681-685
62. Mori T., Kawara S., Shinozaki M., et al. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: a mouse fibrosis model. J Cell Physiol 181 1 (1999) 153-159
63. Colwell A.S., Phan T.-T., Kong W., et al. Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation. Plast Reconstr Surg 116 5 (2005) 1387-1390 [discussion: 1391-82]
64. Shi-Wen X., Leask A., and Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev 19 2 (2008) 133-144
65. Stratton R., Shiwen X., Martini G., et al. Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. J Clin Invest 108 2 (2001) 241-250
66. Abraham D. Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?. Rheumatology (Oxford) 47 Suppl 5 (2008) v8-v9
67. Jones J.I., and Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16 1 (1995) 3-34
68. Rolfe K.J., Cambrey A.D., Richardson J., et al. Dermal fibroblasts derived from fetal and postnatal humans exhibit distinct responses to insulin like growth factors. BMC Dev Biol 7 124 (2007) 1-13
69. Miele C., Rochford J.J., Filippa N., et al. Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J Biol Chem 275 28 (2000) 21695-21702
70. Hill D.J., Logan A., McGarry M., et al. Control of protein and matrix-molecule synthesis in isolated ovine fetal growth-plate chondrocytes by the interactions of basic fibroblast growth factor, insulin-like growth factors-I and -II, insulin and transforming growth factor-beta 1. J Endocrinol 133 3 (1992) 363-373
71. Goldstein R.H., Poliks C.F., Pilch P.F., et al. Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts. Endocrinology 124 2 (1989) 964-970
72. Ghahary A., Shen Q., Shen Y.J., et al. Induction of transforming growth factor beta 1 by insulin-like growth factor-1 in dermal fibroblasts. J Cell Physiol 174 3 (1998) 301-309
73. Steenfos H.H., and Jansson J.O. Gene expression of insulin-like growth factor-I and IGF-I receptor during wound healing in rats. Eur J Surg 158 6-7 (1992) 327-331
74. Ghahary A., Shen Y.J., Nedelec B., et al. Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. J Invest Dermatol 106 3 (1996) 476-481
75. Ghahary A., Shen Y.J., Wang R., et al. Expression and localization of insulin-like growth factor-1 in normal and post-burn hypertrophic scar tissue in human. Mol Cell Biochem 183 1-2 (1998) 1-9
76. Tredget E.E., Nedelec B., Scott P.G., et al. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am 77 3 (1997) 701-730
77. Ghahary A., Shen Y.J., Nedelec B., et al. Interferons gamma and alpha-2b differentially regulate the expression of collagenase and tissue inhibitor of metalloproteinase-1 messenger RNA in human hypertrophic and normal dermal fibroblasts. Wound Repair Regen 3 2 (1995) 176-184
78. Nolte S.V., Xu W., Rennekampff H.-O., et al. Diversity of fibroblasts-a review on implications for skin tissue engineering. Cells Tissues Organs 187 3 (2008) 165-176
79. Rossio-Pasquier P., Casanova D., Jomard A., et al. Wound healing of human skin transplanted onto the nude mouse after a superficial excisional injury: human dermal reconstruction is achieved in several steps by two different fibroblast subpopulations. Arch Dermatol Res 291 11 (1999) 591-599
80. Wang J., Dodd C., Shankowsky H.A., et al. Deep dermal fibroblasts contribute to hypertrophic scarring. Lab Invest 88 12 (2008) 1278-1290
81. Majno G., Gabbiani G., Hirschel B.J., et al. Contraction of granulation tissue in vitro: similarity to smooth muscle. Science 173 996 (1971) 548-550
82. Hinz B., and Gabbiani G. Cell-matrix and cell-cell contacts of myofibroblasts: role in connective tissue remodeling. Thromb Haemost 90 6 (2003) 993-1002
83. Sappino A.P., Schurch W., and Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 63 2 (1990) 144-161
84. Nedelec B., Ghahary A., Scott P.G., et al. Control of wound contraction. Basic and clinical features. Hand Clin 16 2 (2000) 289-302
85. Ehrlich H.P., Desmouliere A., Diegelmann R.F., et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 145 1 (1994) 105-113
86. Junker J.P.E., Kratz C., Tollback A., et al. Mechanical tension stimulates the transdifferentiation of fibroblasts into myofibroblasts in human burn scars. Burns 34 7 (2008) 942-946
87. Moulin V.R., Larochelle S.B., Langlois C.L., et al. Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors. J Cell Physiol 198 3 (2004) 350-358
88. Bucala R., Spiegel L.A., Chesney J., et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1 1 (1994) 71-81
89. Wang J.F., Jiao H., Stewart T.L., et al. Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen 15 1 (2007) 113-121
90. Abe R., Donnelly S.C., Peng T., et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166 12 (2001) 7556-7562
91. Moeller A., Gilpin S., Ask K., et al. Circulating fibrocytes are an indicator for poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179 7 (2009) 588-594
92. Phillips R.J. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114 3 (2004) 438-446
93. Bellini A., and Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 87 9 (2007) 858-870
94. Medbury H.J., Tarran S.L.S., Guiffre A.K., et al. Monocytes contribute to the atherosclerotic cap by transformation into fibrocytes. Int Angiol 27 2 (2008) 114-123
95. Barth P.J., Ebrahimsade S., Hellinger A., et al. CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Arch 440 2 (2002) 128-133
96. Nimphius W., Moll R., Olbert P., et al. CD34+ fibrocytes in chronic cystitis and noninvasive and invasive urothelial carcinomas of the urinary bladder. Virchows Arch 450 2 (2007) 179-185
97. Yang L., Scott P.G., Giuffre J., et al. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 82 9 (2002) 1183-1192
98. Yang L., Scott P.G., Dodd C., et al. Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen 13 4 (2005) 398-404
99. Holland A.J.A., Tarran S.L.S., Medbury H.J., et al. Are fibrocytes present in pediatric burn wounds?. J Burn Care Res 29 4 (2008) 619-626
100. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J Pathol 214 2 (2008) 199-210
101. Hong K.M., Belperio J.A., Keane M.P., et al. Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. J Biol Chem 282 31 (2007) 22910-22920
102. Pilling D., Buckley C.D., Salmon M., et al. Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol 171 10 (2003) 5537-5546
103. Pilling D., Roife D., Wang M., et al. Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J Immunol 179 6 (2007) 4035-4044
104. Chesney J., Bacher M., Bender A., et al. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A 94 12 (1997) 6307-6312
105. Balmelli C., Alves M.P., Steiner E., et al. Responsiveness of fibrocytes to Toll-like receptor danger signals. Immunobiology 212 9-10 (2007) 693-699
106. Hartlapp I., Abe R., Saeed R.W., et al. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 15 12 (2001) 2215-2224
107. Deitch E.A., Wheelahan T.M., Rose M.P., et al. Hypertrophic burn scars: analysis of variables. J Trauma 23 10 (1983) 895-898
108. Colwell A.S., Yun R., Krummel T.M., et al. Keratinocytes modulate fetal and postnatal fibroblast transforming growth factor-beta and Smad expression in co-culture. Plast Reconstr Surg 119 5 (2007) 1440-1445
109. Ghahary A., and Ghaffari A. Role of keratinocyte-fibroblast cross-talk in development of hypertrophic scar. Wound Repair Regen 15 Suppl 1 (2007) S46-S53
110. Werner S., Krieg T., and Smola H. Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol 127 5 (2007) 998-1008
111. Ghaffari A., Kilani R.T., and Ghahary A. Keratinocyte-conditioned media regulate collagen expression in dermal fibroblasts. J Invest Dermatol 129 2 (2009) 340-347
112. Amjad S.B., Carachi R., and Edward M. Keratinocyte regulation of TGF-beta and connective tissue growth factor expression: a role in suppression of scar tissue formation. Wound Repair Regen 15 5 (2007) 748-755
113. Ghahary A., Marcoux Y., Karimi-Busheri F., et al. Differentiated keratinocyte-releasable stratifin (14-3-3 sigma) stimulates MMP-1 expression in dermal fibroblasts. J Invest Dermatol 124 1 (2005) 170-177
114. Bellemare J., Roberge C.J., Bergeron D., et al. Epidermis promotes dermal fibrosis: role in the pathogenesis of hypertrophic scars. J Pathol 206 1 (2005) 1-8
115. Armour A., Scott P.G., and Tredget E.E. Cellular and molecular pathology of HTS: basis for treatment. Wound Repair Regen 15 Suppl 1 (2007) S6-17
116. van der Veer W.M., Bloemen M.C.T., Ulrich M.M.W., et al. Potential cellular and molecular causes of hypertrophic scar formation. Burns 35 1 (2009) 15-29
117. Sunderkotter C., Steinbrink K., Goebeler M., et al. Macrophages and angiogenesis. J Leukoc Biol 55 3 (1994) 410-422
118. Ishida Y., Gao J.-L., and Murphy P.M. Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J Immunol 180 1 (2008) 569-579
119. Goodman R.E., Nestle F., Naidu Y.M., et al. Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma. J Immunol 152 11 (1994) 5189-5198
120. Hauser C. The interaction between langerhans cells and CD4+ T cells. J Dermatol 19 11 (1992) 722-725
121. Romagnani S. Th1 and Th2 in human diseases. Clin Immunol Immunopathol 80 3 Pt 1 (1996) 225-235
122. Mosmann T.R., and Coffman R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7 (1989) 145-173
123. Wang J., Jiao H., Stewart T.L., et al. Increased TGF-beta-producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring. Wound Repair Regen 15 4 (2007) 530-539
124. Wynn T.A. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 4 8 (2004) 583-594
125. Sandler N.G., Mentink-Kane M.M., Cheever A.W., et al. Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J Immunol 171 7 (2003) 3655-3667
126. Kilani R.T., Delehanty M., Shankowsky H.A., et al. Fluorescent-activated cell-sorting analysis of intracellular interferon-gamma and interleukin-4 in fresh and frozen human peripheral blood T-helper cells. Wound Repair Regen 13 4 (2005) 441-449
127. Tredget E.E., Yang L., Delehanty M., et al. Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury. J Interferon Cytokine Res 26 3 (2006) 179-189
128. Wang H.-J., Pieper J., Schotel R., et al. Stimulation of skin repair is dependent on fibroblast source and presence of extracellular matrix. Tissue Eng 10 7-8 (2004) 1054-1064
129. Niessen F.B., Spauwen P.H., Schalkwijk J., et al. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 104 5 (1999) 1435-1458
130. Linares H.A., Kischer C.W., Dobrkovsky M., et al. The histiotypic organization of the hypertrophic scar in humans. J Invest Dermatol 59 4 (1972) 323-331
131. Kischer C.W. Collagen and dermal patterns in the hypertrophic scar. Anat Rec 179 1 (1974) 137-145
132. Hayakawa T., Hashimoto Y., Myokei Y., et al. Changes in type of collagen during the development of human post-burn hypertrophic scars. Clin Chim Acta 93 1 (1979) 119-125
133. Bailey A.J., Bazin S., Sims T.J., et al. Characterization of the collagen of human hypertrophic and normal scars. Biochim Biophys Acta 405 2 (1975) 412-421
134. Ehrlich H.P., and White B.S. The identification of alpha A and alpha B collagen chains in hypertrophic scar. Exp Mol Pathol 34 1 (1981) 1-8
135. Lapiere C.M., Nusgens B., and Pierard G.E. Interaction between collagen type I and type III in conditioning bundles organization. Connect Tissue Res 5 1 (1977) 21-29
136. Adachi E., and Hayashi T. In vitro formation of hybrid fibrils of type V collagen and type I collagen. Limited growth of type I collagen into thick fibrils by type V collagen. Connect Tissue Res 14 4 (1986) 257-266
137. Birk D.E., Fitch J.M., Babiarz J.P., et al. Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter. J Cell Sci 95 Pt 4 (1990) 649-657
138. Scott P.G., Dodd C.M., Tredget E.E., et al. Chemical characterization and quantification of proteoglycans in human post-burn hypertrophic and mature scars. Clin Sci (Lond) 90 5 (1996) 417-425
139. Zhang G., Ezura Y., Chervoneva I., et al. Decorin regulates assembly of collagen fibrils and acquisition of biomechanical properties during tendon development. J Cell Biochem 98 6 (2006) 1436-1449
140. Raspanti M., Viola M., Sonaggere M., et al. Collagen fibril structure is affected by collagen concentration and decorin. Biomacromolecules 8 7 (2007) 2087-2091
141. Zhang Z., Li X.-J., Liu Y., et al. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts. Burns 33 5 (2007) 634-641
142. Yamaguchi Y., Mann D.M., and Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346 6281 (1990) 281-284
143. Logan A., Baird A., and Berry M. Decorin attenuates gliotic scar formation in the rat cerebral hemisphere. Exp Neurol 159 2 (1999) 504-510
144. Kolb M., Margetts P.J., Galt T., et al. Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am J Respir Crit Care Med 163 3 Pt 1 (2001) 770-777
145. Bittner K., Liszio C., Blumberg P., et al. Modulation of collagen gel contraction by decorin. Biochem J 314 Pt 1 (1996) 159-166
146. Ferdous Z., Wei V.M., Iozzo R., et al. Decorin-transforming growth factor-b interaction regulates matrix organization and mechanical characteristics of three-dimensional collagen matrices. J Biol Chem 282 49 (2007) 35887-35898
147. Tredget E.E. Pathophysiology and treatment of fibroproliferative disorders following thermal injury. Ann N Y Acad Sci 888 (1999) 165-182
148. Catty R.H. Healing and contraction of experimental full-thickness wounds in the human. Br J Surg 52 (1965) 542-548
149. Ramirez A.T., Soroff H.S., Schwartz M.S., et al. Experimental wound healing in man. Surg Gynecol Obstet 128 2 (1969) 283-293
150. Ramos M.L., Gragnani A., and Ferreira L.M. Is there an ideal animal model to study hypertrophic scarring?. J Burn Care Res 29 2 (2008) 363-368
151. Carlson M.A., and Longaker M.T. The fibroblast-populated collagen matrix as a model of wound healing: a review of the evidence. Wound Repair Regen 12 2 (2004) 134-147
152. Ryan G.B., Cliff W.J., Gabbiani G., et al. Myofibroblasts in human granulation tissue. Hum Pathol 5 1 (1974) 55-67
153. Scott P.G., Ghahary A., Chambers M., et al. Biological basis of hypertrophic scarring. Adv Struct Biol 3 (1994) 157-202
154. Harris A.K., Stopak D., and Wild P. Fibroblast traction as a mechanism for collagen morphogenesis. Nature 290 5803 (1981) 249-251
155. Harris A.K., Wild P., and Stopak D. Silicone rubber substrata: a new wrinkle in the study of cell locomotion. Science 208 4440 (1980) 177-179
156. Ehrlich H.P. Wound closure: evidence of cooperation between fibroblasts and collagen matrix. Eye 2 Pt 2 (1988) 149-157
157. Squier C.A. The effect of stretching on formation of myofibroblasts in mouse skin. Cell Tissue Res 220 2 (1981) 325-335
158. Bell E., Ivarsson B., and Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci U S A 76 3 (1979) 1274-1278
159. Nishiyama T., Tominaga N., Nakajima K., et al. Quantitative evaluation of the factors affecting the process of fibroblast-mediated collagen gel contraction by separating the process into three phases. Coll Relat Res 8 3 (1988) 259-273
160. Tomasek J.J., and Hay E.D. Analysis of the role of microfilaments and microtubules in acquisition of bipolarity and elongation of fibroblasts in hydrated collagen gels. J Cell Biol 99 2 (1984) 536-549
161. Buttle D.J., and Ehrlich H.P. Comparative studies of collagen lattice contraction utilizing a normal and a transformed cell line. J Cell Physiol 116 2 (1983) 159-166
162. Delvoye P., Mauch C., Krieg T., et al. Contraction of collagen lattices by fibroblasts from patients and animals with heritable disorders of connective tissue. Br J Dermatol 115 2 (1986) 139-146
163. Ehrlich H.P., and Rajaratnam J.B. Cell locomotion forces versus cell contraction forces for collagen lattice contraction: an in vitro model of wound contraction. Tissue Cell 22 4 (1990) 407-417
164. Montesano R., and Orci L. Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. Proc Natl Acad Sci U S A 85 13 (1988) 4894-4897
165. Reed M.J., Vernon R.B., Abrass I.B., et al. TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors. J Cell Physiol 158 1 (1994) 169-179
166. Clark R.A., Folkvord J.M., Hart C.E., et al. Platelet isoforms of platelet-derived growth factor stimulate fibroblasts to contract collagen matrices. J Clin Invest 84 3 (1989) 1036-1040
167. Nedelec B., Shen Y.J., Ghahary A., et al. The effect of interferon alpha 2b on the expression of cytoskeletal proteins in an in vitro model of wound contraction. J Lab Clin Med 126 5 (1995) 474-484
168. Nedelec B., Dodd C.M., Scott P.G., et al. Effect of interferon-alpha2b on guinea pig wound closure and the expression of cytoskeletal proteins in vivo. Wound Repair Regen 6 3 (1998) 202-212
169. Ehrlich H.P. The modulation of contraction of fibroblast populated collagen lattices by types I, II, and III collagen. Tissue Cell 20 1 (1988) 47-50
170. Ehrlich H.P., and Hembry R.M. A comparative study of fibroblasts in healing freeze and burn injuries in rats. Am J Pathol 117 2 (1984) 218-224
171. Stone P.A., and Madden J.W. Effect of primary and delayed split skin grafting on wound contraction. Surg Forum 25 (1974) 41-44
172. Rudolph R. Inhibition of myofibroblasts by skin grafts. Plast Reconstr Surg 63 4 (1979) 473-480
173. Desmouliere A., Redard M., Darby I., et al. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146 1 (1995) 56-66
174. Garbin S., Pittet B., Montandon D., et al. Covering by a flap induces apoptosis of granulation tissue myofibroblasts and vascular cells. Wound Repair Regen 4 2 (1996) 244-251
175. Shin D., and Minn K.W. The effect of myofibroblast on contracture of hypertrophic scar. Plast Reconstr Surg 113 2 (2004) 633-640
176. Garner W.L., Rittenberg T., Ehrlich H.P., et al. Hypertrophic scar fibroblasts accelerate collagen gel contraction. Wound Repair Regen 3 2 (1995) 185-191
177. Derderian C.A., Bastidas N., Lerman O.Z., et al. Mechanical strain alters gene expression in an in vitro model of hypertrophic scarring. Ann Plast Surg 55 1 (2005) 69-75
178. Larrabee Jr. W.F., East C.A., Jaffe H.S., et al. Intralesional interferon gamma treatment for keloids and hypertrophic scars. Arch Otolaryngol Head Neck Surg 116 10 (1990) 1159-1162
179. Macintyre L., and Baird M. Pressure garments for use in the treatment of hypertrophic scars-a review of the problems associated with their use. Burns 32 1 (2006) 10-15
180. Mustoe T.A., Cooter R.D., Gold M.H., et al. International clinical recommendations on scar management. Plast Reconstr Surg 110 2 (2002) 560-571
181. Anzarut A., Olson J., Singh P., et al. The effectiveness of pressure garment therapy for the prevention of abnormal scarring after burn injury: a meta-analysis. J Plast Reconstr Aesthet Surg 62 1 (2009) 77-84
182. Perkins K., Davey R.B., and Wallis K.A. Silicone gel: a new treatment for burn scars and contractures. Burns Incl Therm Inj 9 3 (1983) 201-204
183. Mutalik S. Treatment of keloids and hypertrophic scars. Indian J Dermatol Venereol Leprol 71 1 (2005) 3-8
184. Mahnoush M. Effects of silicone gel on burn scars. Burns 35 1 (1990) 70-74
185. Kamolz L.P., Kitzinger H.B., Karle B., et al. The treatment of hand burns. Burns 35 3 (2008) 327-337
186. Prasad J.K., Bowden M.L., and Thomson P.D. A review of the reconstructive surgery needs of 3167 survivors of burn injury. Burns 17 4 (1991) 302-305
187. Ketchum L.D., Smith J., Robinson D.W., et al. The treatment of hypertrophic scar, keloid and scar contracture by triamcinolone acetonide. Plast Reconstr Surg 38 3 (1966) 209-218
188. Al-Attar A., Mess S., Thomassen J.M., et al. Keloid pathogenesis and treatment. Plast Reconstr Surg 117 1 (2006) 286-300
189. Berman B., Viera M.H., Amini S., et al. Prevention and management of hypertrophic scars and keloids after burns in children. J Craniofac Surg 19 4 (2008) 989-1006
190. Atiyeh B.S. Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesthetic Plast Surg 31 5 (2007) 468-492 [discussion: 493-4]
191. Lama P.J., and Fechtner R.D. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 48 3 (2003) 314-346
192. Apikian M., and Goodman G. Intralesional 5-fluorouracil in the treatment of keloid scars. Australas J Dermatol 45 2 (2004) 140-143
193. Nandakumar D.N., Koner B.C., Vinayagamoorthi R., et al. Activation of NF-kappaB in lymphocytes and increase in serum immunoglobulin in hyperthyroidism: possible role of oxidative stress. Immunobiology 213 5 (2008) 409-415
194. Fitzpatrick R.E. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 25 3 (1999) 224-232
195. Oh C.K., Son H.S., Kwon Y.W., et al. Intralesional fluorouracil injection in infantile digital fibromatosis. Arch Dermatol 141 5 (2005) 549-550
196. Chen M.A., and Davidson T.M. Scar management: prevention and treatment strategies. Curr Opin Otolaryngol Head Neck Surg 13 4 (2005) 242-247
197. Berman B., Villa A.M., and Ramirez C.C. Novel opportunities in the treatment and prevention of scarring. J Cutan Med Surg 8 Suppl 3 (2004) 32-36
198. Tredget E.E., Wang R., Shen Q., et al. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo. J Interferon Cytokine Res 20 2 (2000) 143-151
199. Yokozeki M., Baba Y., Shimokawa H., et al. Interferon-gamma inhibits the myofibroblastic phenotype of rat palatal fibroblasts induced by transforming growth factor-beta1 in vitro. FEBS Lett 442 1 (1999) 61-64
200. Higashi K., Inagaki Y., Fujimori K., et al. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3. J Biol Chem 278 44 (2003) 43470-43479
201. Davison S.P., Mess S., Kauffman L.C., et al. Ineffective treatment of keloids with interferon alpha-2b. Plast Reconstr Surg 117 1 (2006) 247-252
202. O'Kane S., and Ferguson M.W. Transforming growth factor beta and wound healing. Int J Biochem Cell Biol 29 1 (1997) 63-78
203. Roberts A.B. Transforming growth factor-beta: activity and efficacy in animal models of wound healing. Wound Repair Regen 3 4 (1995) 408-418
204. Shah M., Foreman D.M., and Ferguson M.W. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 108 Pt 3 (1995) 985-1002
205. Durani P., Occleston N., O'Kane S., et al. Avotermin: a novel antiscarring agent. Int J Low Extrem Wounds 7 3 (2008) 160-168
206. Ferguson M.W., Duncan J., Bond J., et al. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies. Lancet 373 9671 (2009) 1264-1274
207. Lee K.K., Mehrany K., and Swanson N.A. Surgical revision. Dermatol Clin 23 1 (2005) 141-150 vii
208. Alster T.S. Improvement of erythematous and hypertrophic scars by the 585-nm flashlamp-pumped pulsed dye laser. Ann Plast Surg 32 2 (1994) 186-190
209. Alster T.S., and Williams C.M. Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser. Lancet 345 8959 (1995) 1198-1200
210. Bouzari N., Davis S.C., and Nouri K. Laser treatment of keloids and hypertrophic scars. Int J Dermatol 46 1 (2007) 80-88
211. Har-Shai Y., Amar M., and Sabo E. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast Reconstr Surg 111 6 (2003) 1841-1852
212. Atiyeh B.S., Gunn S.W., and Hayek S.N. State of the art in burn treatment. World J Surg 29 2 (2005) 131-148
213. Wu Y., Wang J., Scott P.G., et al. Bone marrow-derived stem cells in wound healing: a review. Wound Repair Regen 15 Suppl 1 (2007) S18-S26
214. O'Connor N.E., Mulliken J.B., and Banks-Schlegel S. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1 8211 (1981) 75-78
215. Seo Y.K., Song K.Y., Kim Y.J., et al. Wound healing effect of acellular artificial dermis containing extracellular matrix secreted by human skin fibroblasts. Artif Organs 31 7 (2007) 509-520
216. Sahota P.S., Burn J.L., Brown N.J., et al. Approaches to improve angiogenesis in tissue-engineered skin. Wound Repair Regen 12 6 (2004) 635-642
217. Kataoka K., Medina R.J., Kageyama T., et al. Participation of adult mouse bone marrow cells in reconstitution of skin. Am J Pathol 163 4 (2003) 1227-1231
218. Nakagawa H., Akita S., Fukui M., et al. Human mesenchymal stem cells successfully improve skin-substitute wound healing. Br J Dermatol 153 1 (2005) 29-36